SCHEMBL7785658

SCHEMBL7785658

COc1ccc(C(=O)NC(CC(=O)O)c2cccc(N(NC(=N)N)S(=O)(=O)c3ccccc3)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CTSA P10619 2/20 0.43
ITGB3 P05106 2/20 0.42
ITGAV P06756 1/20 0.42
HCRTR1 O43613 1/20 0.41
HCRTR2 O43614 1/20 0.41
UTS2R Q9UKP6 2/20 0.41
MAPK1 P28482 2/20 0.41
CHEK1 O14757 1/20 0.41
ROCK2 O75116 1/20 0.41
RPS6KA5 O75582 1/20 0.41
MAP4K4 O95819 1/20 0.41
CHEK2 O96017 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7785607 0.93 LMNA (0.46) LMNAMAPTKMT2AMEN1CYP3A4
SCHEMBL7194899 0.91 ITGB3 (0.44) LMNAMAPTKMT2AMEN1CYP3A4
SCHEMBL7789969 0.91 CYP26A1 (0.42) LMNAMAPTSMN1; SMN2CTSAITGB3
SCHEMBL7781206 0.90 ITGB3 (0.42) MAPTKMT2AMEN1CTSAITGB3
SCHEMBL7788355 0.89 MMP12 (0.47) LMNASMN1; SMN2ITGB3ITGAVF10
SCHEMBL7790178 0.89 CTSA (0.41) MAPTKMT2AMEN1CTSAITGB3
SCHEMBL7788749 0.88 ITGB3 (0.44) LMNAMAPTKMT2AMEN1CYP3A4
SCHEMBL7790163 0.87 ALDH1A1 (0.46) KMT2AMEN1CYP3A4CYP2C19ITGB3
SCHEMBL7781180 0.87 EEF2K (0.46) CTSAITGB3F10ITGA2B
SCHEMBL7790073 0.86 CYP26A1 (0.46) LMNAMAPTKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147079-A2 BETA-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS Bayer Aktiengesellschaft (DE) 2001-10-24 EP disclosed
WO-2000041469-A2 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2000-07-20 WO disclosed